420 With CNW - White House Noncommittal On Biden's View Of DOJ's Stand On Cannabis Reclassification

5/17/2024 11:17:24 PM

(MENAFN- Investor Brand Network) The White House
hasn't disclosed whether President Joseph Biden
backs the U.S. Department of Justice's (DOJ) proposal to reclassify cannabis after a review he initiated. During a conversation with Karine Jean-Pierre, the White House press secretary, reporters asked questions regarding the president's stance on the DOJ's proposal to shift marijuana from Schedule I to III.

Jean Pierre responded by noting that Biden's administration would let the review process unfold, so she wouldn't“preempt the matter.” She also stressed the...

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text
CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:
/Disclaimer

CannabisNewsWire
Denver, CO

303.498.7722 Office
...

CannabisNewsWire is powered by
IBN

MENAFN17052024000224011066ID1108228043

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.